Insider Buying: Vitalhub (TSE:VHI) Director Purchases 50,000 Shares of Stock

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen acquired 50,000 shares of Vitalhub stock in a transaction that occurred on Thursday, March 26th. The stock was purchased at an average cost of C$6.99 per share, for a total transaction of C$349,500.00. Following the completion of the transaction, the director directly owned 50,000 shares in the company, valued at C$349,500. This trade represents a ∞ increase in their ownership of the stock.

Francis Nelson Shen also recently made the following trade(s):

• On Tuesday, March 24th, Francis Nelson Shen acquired 439,600 shares of Vitalhub stock. The stock was purchased at an average cost of C$7.00 per share, with a total value of C$3,077,200.00.

Vitalhub Price Performance

Shares of TSE:VHI traded down C$0.05 during trading hours on Friday, hitting C$6.93. 208,775 shares of the company’s stock traded hands, compared to its average volume of 359,939. The firm has a market capitalization of C$438.20 million, a P/E ratio of 69.30, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65. The business has a fifty day moving average price of C$8.10 and a 200-day moving average price of C$9.35. Vitalhub Corp. has a 1 year low of C$6.67 and a 1 year high of C$14.64.

Vitalhub (TSE:VHI) last issued its quarterly earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%.The firm had revenue of C$31.39 million for the quarter. As a group, equities analysts predict that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on VHI shares. Raymond James Financial decreased their target price on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research report on Tuesday. ATB Cormark Capital Markets reduced their price target on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 10th. Royal Bank Of Canada decreased their price objective on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a report on Monday, January 26th. Finally, Scotiabank lowered their price objective on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. Based on data from MarketBeat.com, Vitalhub has an average rating of “Buy” and a consensus price target of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.